Surgical Treatment of Lymphedema: A Systematic Review and Meta-Analysis of Controlled Trials. Results of a Consensus Conference
- PMID: 33761519
- DOI: 10.1097/PRS.0000000000007783
Surgical Treatment of Lymphedema: A Systematic Review and Meta-Analysis of Controlled Trials. Results of a Consensus Conference
Abstract
Background: The goal of this consensus conference, sponsored by the American Association of Plastic Surgeons, was to perform a systematic review and meta-analysis of controlled trials to examine both the benefits and risks of surgical treatment and surgical prevention of upper and lower extremity lymphedema.
Methods: The panel met in Boston for a 3-day, face-to-face meeting in July of 2017. After an exhaustive review of the existing literature, the authors created consensus recommendations using the Grading of Recommendations, Assessment, Development and Evaluation criteria. Important directions for future research were also identified.
Results: There is evidence to support that lymphovenous anastomosis can be effective in reducing severity of lymphedema (grade 1C). There is evidence to support that vascular lymph node transplantation can be effective in reducing severity of lymphedema (grade 1B). Currently, there is no consensus on which procedure (lymphovenous bypass versus vascular lymph node transplantation) is more effective (grade 2C). A few studies show that prophylactic lymphovenous bypass in patients undergoing extremity lymphadenectomy may reduce the incidence of lymphedema (grade 1B). More studies with longer follow-up are required to confirm this benefit. Debulking procedures such as liposuction are effective in addressing a nonfluid component such as fat involving lymphedema (grade 1C). There is a role for liposuction combined with physiologic procedures although the timing of each procedure is currently unresolved (grade 1C).
Conclusions: Many studies seem to support some efficacy of lymphovenous bypass and vascular lymph node transplantation. Many studies show the important role of lymphedema therapy and other procedures such as liposuction and debulking. The management of lymphedema is a challenging field with many promising advances. However, many questions remain unanswered.
Copyright © 2021 by the American Society of Plastic Surgeons.
Similar articles
-
[Lympho-reconstructive microsurgery for secondary lymphedema: Consensus of the German-Speaking Society for Microsurgery of Peripheral Nerves and Vessels (DAM) on indication, diagnostic and therapy by lymphovenous anastomosis (LVA) and vascularized lymph node transfer (VLNT)].Handchir Mikrochir Plast Chir. 2019 Dec;51(6):424-433. doi: 10.1055/a-0874-2212. Epub 2019 May 8. Handchir Mikrochir Plast Chir. 2019. PMID: 31067594 German.
-
Comparison of Outcomes between Side-to-End and End-to-End Lymphovenous Anastomoses for Early-Grade Extremity Lymphedema.Plast Reconstr Surg. 2019 Aug;144(2):486-496. doi: 10.1097/PRS.0000000000005870. Plast Reconstr Surg. 2019. PMID: 31348365
-
A prospective analysis of 100 consecutive lymphovenous bypass cases for treatment of extremity lymphedema.Plast Reconstr Surg. 2013 Nov;132(5):1305-1314. doi: 10.1097/PRS.0b013e3182a4d626. Plast Reconstr Surg. 2013. PMID: 24165613
-
The effect of prophylactic lymphovenous anastomosis and shunts for preventing cancer-related lymphedema: a systematic review and meta-analysis.Microsurgery. 2018 Jul;38(5):576-585. doi: 10.1002/micr.30180. Epub 2017 Mar 28. Microsurgery. 2018. PMID: 28370317
-
Patient-reported outcomes following lymph reconstructive surgery in lower limb lymphedema: A systematic review of literature.J Vasc Surg Venous Lymphat Disord. 2021 May;9(3):811-819.e2. doi: 10.1016/j.jvsv.2020.11.022. Epub 2020 Dec 10. J Vasc Surg Venous Lymphat Disord. 2021. PMID: 33309902
Cited by
-
Extremely Low Incidence of Local-Regional Recurrences Observed Among T1-2 N1 (1 or 2 Positive SLNs) Breast Cancer Patients Receiving Upfront Mastectomy Without Completion Axillary Node Dissection.Ann Surg Oncol. 2023 Nov;30(12):7015-7025. doi: 10.1245/s10434-023-13942-1. Epub 2023 Jul 17. Ann Surg Oncol. 2023. PMID: 37458948
-
Lymphatic Fistula Treatment: Indocyanine Green Lymphography-guided Microsurgery.Plast Reconstr Surg Glob Open. 2024 Oct 15;12(10):e6168. doi: 10.1097/GOX.0000000000006168. eCollection 2024 Oct. Plast Reconstr Surg Glob Open. 2024. PMID: 39410971 Free PMC article.
-
Etiology and treatment of cancer-related secondary lymphedema.Clin Exp Metastasis. 2024 Aug;41(4):525-548. doi: 10.1007/s10585-023-10232-8. Epub 2023 Sep 30. Clin Exp Metastasis. 2024. PMID: 37777696 Review.
-
Noncontrast Ultra-High-Frequency Ultrasound for Preoperative Lymphovenous Mapping in Patients Undergoing Lymphaticovenous Anastomosis Surgery for Extremity Lymphedema.AJR Am J Roentgenol. 2025 Mar;224(3):e2432001. doi: 10.2214/AJR.24.32001. Epub 2024 Oct 23. AJR Am J Roentgenol. 2025. PMID: 39440799
-
Single and combined impacts of irradiation and surgery on lymphatic vasculature and fibrosis associated to secondary lymphedema.Front Pharmacol. 2022 Oct 18;13:1016138. doi: 10.3389/fphar.2022.1016138. eCollection 2022. Front Pharmacol. 2022. PMID: 36330083 Free PMC article.
References
-
- Guyatt G, Gutterman D, Baumann MH, et al. Grading strength of recommendations and quality of evidence in clinical guidelines: Report from an American College of Chest Physicians task force. Chest. 2006;129:174–181.
-
- Guyatt GH, Oxman AD, Vist GE, et al.; GRADE Working Group. GRADE: An emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924–926.
-
- Schünemann HJ, Oxman AD, Vist GE, et al. Higgins JPT, Green S, eds. Chapter 12: Interpreting results and drawing conclusions. In: Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. 2011.London: Cochrane Collaboration;
-
- Higgins JPT, Altman DG, Sterne JAC. Higgins JPT, Green S, eds. Chapter 8: Assessing risk of bias in included studies. In: Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. 2011.London: Cochrane Collaboration;
-
- Wells GA, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2019Ottawa, Ontario, Canada: Department of Epidemiology and Community Medicine, University of Ottawa; Available at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp . Accessed February 25, 2021.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous